The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Did Accustem finish up at 0.36 USD +0.080 (28.57%)today?
Thanks Bluebelly.With my paper losses it is clear that I am tied in for the long haul-as it looks you are.Any good news to try and raise the sp or even sentiment would be most welcome.
Might see an RNS drop tomorrow morning.
It was mentioned that the TLSA price action on Friday could have been linked to Aridis pharma which surged to +30% then finished -12%, a strange 40% swing.
TLSA finished strongly, +14% on the day and +3.38% after hours.
Unlikely it was the ARDS effect, hopefully a leak and we got some good news to get the SP moving upwards again.
Lampard8: Thanks for the reply. 60% down is not uncommon, but hard to accept. I have my ISA that is 50% down (with 30k Accustem to come) and my wife ISA 30% down and no Accustem. I do not believe you will be waiting 2 years to recover your loses and turn a profit. Some things that we are waiting on in the near term .
The first patient with SPMS was dosed on May 24, 2021 with nasally administered Foralumab. The treatment regimen will continue for six months to examine long-term safety, tolerability and clinical responses. - 9 Weeks of data.
Tiziana Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma. - RNS'd over 11weeks ago.
Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab. to conduct a Phase 2 Proof-of-concept study in Brazil to evaluate the safety, tolerability and efficacy of intranasal Foralumab in hospitalized patients with severe coronavirus disease 2019 (COVID-19) and pulmonary inflammation. Nearly 5 weeks ago.
And Acustem will hopefully be on a separate board in the not to distant future. Jul/Aug ish.
Also:
Hopefully H2 will give us a slow climb to POC for Foralumab & the SP will re-rate to maintain a higher trading range.
GLA
BB
I am informed that we haven’t dosed anyone in Brazil yet on the covid trial. So results can’t have been leaked. Theory invalid. Sorry
24 june the phase 2 covid poc on Brazil started. Scheduled to run for 14 days
My guess is those results have leaked BUT it’s my GUESS
FHI Clinical is partnering up with @TizianaLS on a #phase2study in Brazil. Together we’ll evaluate the safety, tolerability and efficacy of intranasal Foralumab in hospitalized patients with severe COVID-19 and pulmonary inflammation. Learn more here: fhiclinical.com/news-item/tizi…
There are 5 poc in q3/ q4. Covid/ Alzheimer’s and crohns. Any positive outcome will potentially rerate us
On Friday Nasdaq version of tils went up over 14% plus some after hours increase. Was that a leak? Stocktwits rumour is that we have some covid success but that’s from Twitter so who knows?
We have all held this long. No reason to sell now really.
The bod will need cash on just over 12 months. They will find a raise difficult given how the iis didn’t do well last time. The bod have put up a for sale sign on tils. If I were them i would sell sooner rather than later. As that potential cash raise gets closer their negotiating position gets weaker
So imho we will be sold within 6 to 9 months
All just logic of mine. It’s not advice. It’s just what I think
So yes plenty of reasons for the share price to rise and soon
Bluebelly-No I didnt respond to the wrong thread.I have seen so much s**t on this board for the last 10 months about the sp going to turn the corner and re rate, great news on the way etc etc.All false dawns as my £1.50 purchase is now worth £0.64.Thats a fact.Never mind the accustem obloxs.Im not a de-ramper as im desperate for the sp in this share to rise.My question was why did you think it was going to rise to its true value-was there some news received/expected?
Closed at $2.14 after also being up 4% in after hours trading. I think that's about a 20% rise from the previous day's close, overall.
Happy to be corrected if wrong.
Might be good for us on Monday.
Finished even higher...... Good news arriving for Monday?
Leaky leaky?
GLA
Very likely the shorters will be deep fried next week, Yanks are expecting the news about approval of Take Home treatment of Covid, so maybe Monday then. Nasdaq after market $2.21.
I hope the shorters fry
The volume at Nasdaq is quite high, around 1.5m Tlsa shares. If they can sustain the rise at close, we will see Tils open 70p plus next Monday. Hope those shorting in 60s have a chance to close their short then.
Now up 17%, rumour of approval coming mentioned at stocktwits.
Lampard8: would love that to be true but based on what?
It is true - Yahoo Finance chart - Live price= $2.04 (12% up)
Did you respond to the wrong title?
BB
would love that to be true but based on what?Blind faith/hope?no new news on a share thats been sliding rapidly for months.Ive got to hold this for years now to break even so I have no idea what/how you think this will occur?I have read posts like this for months-and originally believed them-but am now 60% down.I look forward to you renewing my confidence at any stage in the next 2 years minimum.
Hopefully the low has been hit this week and it's a rise to true value.
BB